Conversely, the effectiveness of compounded semaglutide is less certain due to the lack of standardized formulations and rigorous testing
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
Monitor your blood sugar levels regularly if you are on glucose-lowering medications to avoid complications and side effects
Sustained weight management is about deploying lots of tools simultaneously: good nutrition, physical activity, healthcare team support, and when appropriate, medications like retatrutide
Frequently Asked Questions Why do GLP-1 users need electrolytes